VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege
Authors:
Open Access
- 2 December 2019
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 60 (15) , 4958-4965
Abstract
Purpose: V-domain immunoglobulin suppressor of T cell activation (VISTA) is a novel immune checkpoint receptor and ligand for regulating T cell proliferation and cytokine production. The purpose of the present study was to determine the role of VISTA in the immune privilege of corneal allografts. Methods: Expression of VISTA mRNA in mouse eyes was assessed with reverse-transcription PCR. Corneas of C57BL/6 mice were orthotopically transplanted into the eyes of BALB/c wild-type recipients treated with anti-VISTA mAb, and graft survival was assessed. A separate set of BALB/c mice treated with anti-VISTA mAb or rat IgG received injection of C57BL/6 splenocytes into the anterior chamber, and induction of allospecific anterior chamber-associated immune deviation (ACAID) was assessed. CD4+ and CD8+ T cells in the spleen were assessed with flow cytometry. Results: VISTA mRNA was constitutively expressed in the cornea, and the expression of VISTA was localized to CD11b+ cells on the corneal stroma. Survival of allografts treated with anti-VISTA mAb was less than that of the control. ACAID was induced less efficiently in BALB/c mice treated with VISTA mAb. The proportions of CD8+ T cells and CD8+ CD103+ T cells (CD8+ T regulatory cells) in the spleen of BALB/c mice treated with anti-VISTA mAb were significantly lower than those of the control. Conclusions: VISTA may play an essential role in the acceptance of corneal allografts via involvement with allospecific ACAID, which suppresses T cell infiltration into the cornea.Keywords
This publication has 34 references indexed in Scilit:
- Immune privilege in corneal transplantationProgress in Retinal and Eye Research, 2019
- Galectin-9-Mediated Protection from Allo-Specific T Cells as a Mechanism of Immune Privilege of Corneal AllograftsPLOS ONE, 2013
- GITR Ligand–Mediated Local Expansion of Regulatory T Cells and Immune Privilege of Corneal AllograftsInvestigative Ophthalmology & Visual Science, 2010
- Review of Ocular Immune Privilege in the Year 2010: Modifying the Immune Privilege of the EyeOcular Immunology and Inflammation, 2010
- B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal AllograftsThe Journal of Immunology, 2006
- See no evil, hear no evil, do no evil: the lessons of immune privilegeNature Immunology, 2006
- The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunityNature Immunology, 2005
- Ocular immune privilege: therapeutic opportunities from an experiment of natureNature Reviews Immunology, 2003
- Survival in High-Risk Eyes of Epithelium-Deprived Orthotopic Corneal Allografts Reconstituted In Vitro with Syngeneic EpitheliumInvestigative Ophthalmology & Visual Science, 2003
- A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosisProceedings of the National Academy of Sciences, 1997